Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

DPP-IV inhibition in the treatment of diabetes

Aug. 20, 1997

Repaglinide gets expedited review status in U.S

Aug. 20, 1997

Genetic Evolutionary Nutrition licenses pyruvate

Aug. 20, 1997

Glucose metabolism gene related to longevity

Aug. 20, 1997

Initial phase III results announced for pramlintide

Aug. 19, 1997

Sequana, Boehringer Mannheim closer to elucidating genetic basis of osteoporosis

Aug. 18, 1997

Ferring permitted to resume marketing of Repronex

Aug. 18, 1997

Alteon receives U.S. patent for AGE cross-link breakers

Aug. 14, 1997

Alkermes issued U.S. patent for ProLease

Aug. 13, 1997

Trovert receives Orphan Drug designation for acromegaly

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...